China (Mainland)
Premiumsupplier
Wholesaler supplier 865363-93-5 EFDA CAS NO.865363-93-5
- FOB Price: USD: 8,500.00-8,500.00 /Gram Get Latest Price
- Min.Order: 10 Metric Ton
- Payment Terms: L/C,T/T,Other
- Available Specifications:
98%(1-1.01)Gram
- Product Details
Keywords
- 865363-93-5 EFDA Wholesaler
- EFDA supplier
- 865363-93-5 EFDA
Quick Details
- ProName: Wholesaler supplier 865363-93-5 EFDA
- CasNo: 865363-93-5
- Molecular Formula: C12 H14 FN5 O3
- Appearance: White powder
- Application: CAS#865363-93-5;Pharmaceutical interme...
- DeliveryTime: Goods in stock
- PackAge: According to customer
- Port: Shanghai
- ProductionCapacity: 1 Kilogram/Month
- Purity: 97%
- Storage: Store in a tightly closed container, i...
- Transportation: Fedex,DHL,TNT,BY SEA and BY AIR
- LimitNum: 10 Metric Ton
- Moisture Content: 5%
Superiority
Islatravir (4′-ethynyl-2-fluoro-2′-deoxyadenosine, EFdA, or MK-8591) is an investigational drug for the treatment of HIV infection.
It is classified as a nucleoside reverse transcriptase translocation inhibitor (NRTTI). Merck is developing a subdermal drug-eluting implant to administer islatravir.
Biological activity
Islatravir has activity against HIV in animal models, and is being studied clinically for HIV treatment and prophylaxis. Islatravir is a nucleoside analog reverse transcriptase translocation inhibitor that unlike other such inhibitors, inhibits HIV through multiple mechanisms, providing rapid suppression of the virus, when tested in macaques and mice.Nevertheless, there are HIV strains resistant to islatravir and research is ongoing.
Wholesaler supplier 865363-93-5 EFDA
Details
Islatravir (4′-ethynyl-2-fluoro-2′-deoxyadenosine, EFdA, or MK-8591) is an investigational drug for the treatment of HIV infection.
It is classified as a nucleoside reverse transcriptase translocation inhibitor (NRTTI). Merck is developing a subdermal drug-eluting implant to administer islatravir.
Biological activity
Islatravir has activity against HIV in animal models, and is being studied clinically for HIV treatment and prophylaxis. Islatravir is a nucleoside analog reverse transcriptase translocation inhibitor that unlike other such inhibitors, inhibits HIV through multiple mechanisms, providing rapid suppression of the virus, when tested in macaques and mice.Nevertheless, there are HIV strains resistant to islatravir and research is ongoing.